Two Sigma Securities, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $159,570 - $207,150	12,107 New	12,107 $192,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $133,709 - $191,196	-25,664 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $124,470 - $155,010	25,664 New	25,664 $136,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $78,693 - $101,479	-26,496 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $78,693 - $134,599	26,496 New	26,496 $79,000
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $40,207 - $76,796	-10,336 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $38,634 - $87,427	-14,309 Reduced 58.06%	10,336 $40,000
Q1 2019 May 15, 2019	BUY	$2.11 - $5.33 $52,000 - $131,357	24,645 New	24,645 $126,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $63,712 - $106,898	-26,658 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $38,096 - $66,783	15,178 Added 132.21%	26,658 $104,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $27,552 - $33,751	11,480	11,480 $29,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.